Share Name | Share Symbol | Market | Type |
---|---|---|---|
New Senior Investment Group Inc | NYSE:SNR | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.82 | 0 | 01:00:00 |
|
☒
Filed by the Registrant
|
| |
☐
Filed by a Party other than the Registrant
|
|
|
For information about Ventas:
Ventas, Inc. 353 N. Clark Street, Suite 3300 Chicago, Illinois 60654 (877) 483-6827 Attn.: Corporate Secretary |
| |
For information about New Senior:
New Senior Investment Group Inc. 55 West 46th Street, Suite 2204 New York, New York 10036 (646) 822-3700 Attn.: Investor Relations |
|
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 8 | | | |
| | | | 18 | | | |
| | | | 19 | | | |
| | | | 19 | | | |
| | | | 23 | | | |
| | | | 25 | | | |
| | | | 26 | | | |
| | | | 27 | | | |
| | | | 29 | | | |
| | | | 31 | | | |
| | | | 32 | | | |
| | | | 32 | | | |
| | | | 41 | | | |
| | | | 46 | | | |
| | | | 53 | | | |
| | | | 56 | | | |
| | | | 61 | | | |
| | | | 61 | | | |
| | | | 62 | | | |
| | | | 62 | | | |
| | | | 62 | | | |
| | | | 63 | | | |
| | | | 64 | | | |
| | | | 64 | | | |
| | | | 64 | | | |
| | | | 64 | | | |
| | | | 65 | | | |
| | | | 66 | | | |
| | | | 66 | | | |
| | | | 66 | | | |
| | | | 67 | | | |
| | | | 67 | | | |
| | | | 68 | | | |
| | | | 68 | | | |
| | | | 68 | | | |
| | | | 68 | | | |
| | | | 69 | | | |
| | | | 70 | | | |
| | | | 71 | | | |
| | | | 74 | | |
| | |
Page
|
| |||
| | | | 75 | | | |
| | | | 76 | | | |
| | | | 77 | | | |
| | | | 77 | | | |
| | | | 78 | | | |
| | | | 81 | | | |
| | | | 82 | | | |
| | | | 83 | | | |
| | | | 85 | | | |
| | | | 85 | | | |
| | | | 85 | | | |
| | | | 86 | | | |
| | | | 87 | | | |
| | | | 90 | | | |
| | | | 105 | | | |
| | | | 113 | | | |
| | | | 118 | | | |
| | | | 121 | | | |
| | | | 123 | | | |
| | | | 125 | | | |
| | | | 133 | | | |
| | | | 133 | | | |
| | | | 134 | | | |
| | | | 135 | | | |
| | | | 135 | | | |
| | | | 136 | | | |
| | | | A-1 | | | |
| | | | B-1 | | |
| | |
Ventas Common Stock
(Close) |
| |
New Senior Common
Stock (Close) |
| |
Equivalent Per Share Value of
Merger Consideration (giving effect to the Exchange Ratio) (Close) |
| |||||||||
June 25, 2021
|
| | | $ | 58.31 | | | | | $ | 6.91 | | | | | $ | 9.10 | | |
August 6, 2021
|
| | | $ | 58.30 | | | | | $ | 9.00 | | | | | $ | 9.10 | | |
Date
|
| |
Ventas Common Stock
|
| |
New Senior Common Stock
|
| ||||||||||||||||||||||||||||||
|
High
|
| |
Low
|
| |
Close
|
| |
High
|
| |
Low
|
| |
Close
|
| ||||||||||||||||||||
June 25, 2021
|
| | | $ | 58.35 | | | | | $ | 57.64 | | | | | $ | 58.31 | | | | | $ | 6.99 | | | | | $ | 6.91 | | | | | $ | 6.91 | | |
August 6, 2021
|
| | | $ | 60.78 | | | | | $ | 58.01 | | | | | $ | 58.30 | | | | | $ | 9.38 | | | | | $ | 8.96 | | | | | $ | 9.00 | | |
Date
|
| |
Ventas Common Stock
|
| |
New Senior Common Stock
|
| ||||||||||||||||||||||||||||||
|
High
|
| |
Low
|
| |
Close
|
| |
High
|
| |
Low
|
| |
Close
|
| ||||||||||||||||||||
June 25, 2021
|
| | | $ | 58.35 | | | | | $ | 57.64 | | | | | $ | 58.31 | | | | | $ | 9.11 | | | | | $ | 9.00 | | | | | $ | 9.10 | | |
August 6, 2021
|
| | | $ | 60.78 | | | | | $ | 58.01 | | | | | $ | 58.30 | | | | | $ | 9.49 | | | | | $ | 9.06 | | | | | $ | 9.10 | | |
Comparable Company
|
| |
AV / EBITDA Multiples
|
| |
P / FFO Multiples
|
| |
P /AFFO Multiples
|
| |
P / (D)
to NAV |
| ||||||||||||||||||||||||||||||
|
2022E
|
| |
2023E
|
| |
2022E
|
| |
2023E
|
| |
2022E
|
| |
2023E
|
| ||||||||||||||||||||||||||
Sabra
|
| | | | 13.2x | | | | | | 13.1x | | | | | | 10.8x | | | | | | 10.7x | | | | | | 11.2x | | | | | | 10.7x | | | | | | 17% | | |
National Health
|
| | | | 14.9x | | | | | | 14.2x | | | | | | 12.6x | | | | | | 12.3x | | | | | | 13.2x | | | | | | 13.0x | | | | | | 20% | | |
CareTrust
|
| | | | 15.5x | | | | | | 14.4x | | | | | | 15.0x | | | | | | 14.5x | | | | | | 14.4x | | | | | | 13.8x | | | | | | 37% | | |
LTC
|
| | | | 15.3x | | | | | | 15.7x | | | | | | 13.9x | | | | | | 14.2x | | | | | | 13.8x | | | | | | 13.7x | | | | | | 25% | | |
Welltower
|
| | | | 24.1x | | | | | | 22.1x | | | | | | 23.9x | | | | | | 21.4x | | | | | | 27.0x | | | | | | 24.0x | | | | | | 46% | | |
Ventas
|
| | | | 19.9x | | | | | | 18.3x | | | | | | 18.6x | | | | | | 16.7x | | | | | | 22.0x | | | | | | 19.5x | | | | | | 27% | | |
New Senior
|
| | | | 19.6x | | | | | | 18.2x | | | | | | 11.5x | | | | | | 11.1x | | | | | | 10.8x | | | | | | 10.0x | | | | | | (7%) | | |
| | |
New Senior
Metric |
| |
Selected Comparable
Company Multiple Range |
| |
Illustrative Share
Price Range |
| ||||||||||||||||||
|
Low
|
| |
High
|
| |
Low
|
| |
High
|
| |||||||||||||||||
P / 2022E FFO Per Share
|
| |
$0.60
|
| | | | 11.2x | | | | | | 13.2x | | | | | $ | 6.74 | | | | | $ | 7.94 | | |
P / 2023E FFO Per Share
|
| |
$0.62
|
| | | | 10.1x | | | | | | 12.1x | | | | | $ | 6.24 | | | | | $ | 7.48 | | |
Average | | | | | | | | | | | | | | | | | | | $ | 6.49 | | | | | $ | 7.71 | | |
| | |
New Senior
Metric |
| |
Selected Comparable
Company Multiple Range |
| |
Illustrative Share
Price Range |
| ||||||||||||||||||
|
Low
|
| |
High
|
| |
Low
|
| |
High
|
| |||||||||||||||||
P / 2022E AFFO Per Share
|
| |
$0.64
|
| | | | 12.4x | | | | | | 14.4x | | | | | $ | 7.93 | | | | | $ | 9.21 | | |
P / 2023E AFFO Per Share
|
| |
$0.69
|
| | | | 10.8x | | | | | | 12.8x | | | | | $ | 7.48 | | | | | $ | 8.86 | | |
Average | | | | | | | | | | | | | | | | | | | $ | 7.71 | | | | | $ | 9.04 | | |
AV / 2022E EBITDA
|
| |
$107 million
|
| | | | 16.7x | | | | | | 17.7x | | | | | $ | 3.31 | | | | | $ | 4.53 | | |
AV / 2023E EBITDA
|
| |
$115 million
|
| | | | 15.8x | | | | | | 16.8x | | | | | $ | 3.71 | | | | | $ | 5.03 | | |
Average | | | | | | | | | | | | | | | | | | | $ | 3.51 | | | | | $ | 4.78 | | |
Premium / (Discount) to Cons. NAV
|
| |
$7.40
|
| | | | (10%) | | | | | | 5% | | | | | $ | 6.66 | | | | | $ | 7.77 | | |
Announcement Date
|
| |
Acquirer
|
| |
Target
|
| |
Premium to
Unaffected Price |
| |||
January 2, 2019
|
| |
Omega Healthcare
|
| |
MedEquities Realty
|
| | | | 51.6% | | |
April 26, 2018
|
| |
Welltower
|
| |
Quality Care Properties
|
| | | | 5.6% | | |
October 8, 2015
|
| |
Blackstone
|
| |
BioMed Realty
|
| | | | 17.5% | | |
May 7, 2017
|
| |
Sabra
|
| |
Care Capital Properties
|
| | | | 7.8% | | |
October 31, 2014
|
| |
Omega Healthcare
|
| |
Aviv REIT
|
| | | | 22.2% | | |
August 13, 2014
|
| |
Health Care REIT
|
| |
HealthLease
|
| | | | 30.8% | | |
June 2, 2014
|
| |
Ventas
|
| |
American Realty Healthcare Trust
|
| | | | 16.2% | | |
December 27, 2011
|
| |
Ventas
|
| |
Cogdell Spencer
|
| | | | 13.6% | | |
February 28, 2011
|
| |
Ventas
|
| |
Nationwide Health Properties
|
| | | | 19.2% | | |
January 19, 2007
|
| |
Ventas
|
| |
Sunrise Senior Living REIT
|
| | | | 41.8% | | |
September 12, 2006
|
| |
Health Care REIT
|
| |
Windrose Medical
|
| | | | 20.1% | | |
November 19, 2003
|
| |
Ventas
|
| |
ElderTrust
|
| | | | 20.3% | | |
August 4, 1999
|
| |
Health Care Property Inc.
|
| |
American Health Prop.
|
| | | | 8.7% | | |
June 8, 1998
|
| |
Healthcare Realty Trust
|
| |
Capstone Cap
|
| | | | 3.2% | | |
| | |
Selected Range
|
| |
New Senior Share Price
|
| |
Implied Share Price
|
| |||||||||||||||||||||
|
1st Quartile
|
| |
3rd Quartile
|
| |
Low
|
| |
High
|
| ||||||||||||||||||||
Premium to Unaffected Price
|
| | | | 13.6% | | | | | | 22.2% | | | | | $ | 6.91 | | | | | $ | 7.85 | | | | | $ | 8.45 | | |
Metrics
|
| |
Implied Exchange Ratio
|
| |||
High
|
| | | | 0.1402x | | |
Last three-month Average
|
| | | | 0.1212x | | |
Current (June 25, 2021)
|
| | | | 0.1185x | | |
Last Year Average
|
| | | | 0.1093x | | |
Average
|
| | | | 0.1048x | | |
Low
|
| | | | 0.0741x | | |
| | |
Fiscal Year Ending December 31,(1)
|
| |||||||||||||||||||||||||||
|
2021 E (1)
|
| |
2022 E
|
| |
2023 E
|
| |
2024 E
|
| |
2025 E
|
| |||||||||||||||||
Total Cash Revenue (2)
|
| | | $ | 321.6 | | | | | $ | 348.8 | | | | | $ | 374.8 | | | | | $ | 396.8 | | | | | $ | 415.5 | | |
Cash NOI (3)
|
| | | $ | 118.2 | | | | | $ | 134.6 | | | | | $ | 147.5 | | | | | $ | 159.7 | | | | | $ | 171.6 | | |
Normalized Funds From Operations (NFFO) (4)
|
| | | $ | 35.4 | | | | | $ | 58.0 | | | | | $ | 70.6 | | | | | $ | 78.8 | | | | | $ | 88.1 | | |
Adjusted Funds From Operations (AFFO) (5)
|
| | | $ | 45.9 | | | | | $ | 67.3 | | | | | $ | 80.2 | | | | | $ | 88.6 | | | | | $ | 96.9 | | |
Dividends Per Share
|
| | | $ | 0.26 | | | | | $ | 0.26 | | | | | $ | 0.26 | | | | | $ | 0.26 | | | | | $ | 0.26 | | |
Name
|
| |
New
Senior Stock Options (#) |
| |
Value ($)
|
| |
New Senior
Restricted Stock Awards and/or New Senior RSU Awards (time- based) (#)(1) |
| |
Value ($)(2)
|
| |
New Senior
RSU Awards (performance- based) (#)(3) |
| |
Value ($)(4)
|
| ||||||||||||||||||
Directors | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Frances Aldrich Sevilla-Sacasa
|
| | | | — | | | | | | — | | | | | | 15,129 | | | | | $ | 133,892 | | | | | | — | | | | | | — | | |
Norman Jenkins
|
| | | | — | | | | | | — | | | | | | 15,129 | | | | | $ | 133,892 | | | | | | — | | | | | | — | | |
Michael Malone
|
| | | | — | | | | | | — | | | | | | 15,129 | | | | | $ | 133,892 | | | | | | — | | | | | | — | | |
David Milner
|
| | | | — | | | | | | — | | | | | | 15,129 | | | | | $ | 133,892 | | | | | | — | | | | | | — | | |
Robert Savage
|
| | | | — | | | | | | — | | | | | | 15,129 | | | | | $ | 133,892 | | | | | | — | | | | | | — | | |
Cassia van der Hoof Holstein
|
| | | | — | | | | | | — | | | | | | 15,129 | | | | | $ | 133,892 | | | | | | — | | | | | | — | | |
Executive Officers | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Susan Givens
|
| | | | 666,666 | | | | | $ | 3,716,663 | | | | | | 390,542 | | | | | $ | 3,653,507 | | | | | | 2,050,114 | | | | | $ | 19,212,816 | | |
Bhairav Patel
|
| | | | 111,100 | | | | | $ | 619,383 | | | | | | 74,741 | | | | | $ | 694,163 | | | | | | 204,416 | | | | | $ | 1,927,051 | | |
Lori Marino
|
| | | | 104,166 | | | | | $ | 338,019 | | | | | | 57,851 | | | | | $ | 534,829 | | | | | | 239,297 | | | | | $ | 2,226,161 | | |
Name
|
| |
Salary and
Target Bonus ($)(1) |
| |
2021 Bonus
($)(2) |
| |
Value ($)
|
| |||||||||
Susan Givens
|
| | | $ | 5,625,000 | | | | | $ | 1,875,000 | | | | | $ | 7,500,000 | | |
Bhairav Patel
|
| | | $ | 1,400,000 | | | | | $ | 525,000 | | | | | $ | 1,925,000 | | |
Lori Marino
|
| | | $ | 1,700,000 | | | | | $ | 637,500 | | | | | $ | 2,337,500 | | |
Named Executive Officer
|
| |
Cash ($)(1)
|
| |
Equity ($)(2)
|
| |
Perquisites /
Benefits ($)(3) (4) |
| |
Total ($)
|
| ||||||||||||
Susan Givens
|
| | | $ | 7,500,000 | | | | | $ | 26,582,986 | | | | | $ | 34,674 | | | | | $ | 34,117,660 | | |
Bhairav Patel
|
| | | $ | 1,925,000 | | | | | $ | 3,240,597 | | | | | $ | 34,674 | | | | | $ | 5,200,271 | | |
Lori Marino
|
| | | $ | 2,337,500 | | | | | $ | 3,099,009 | | | | | $ | 34,674 | | | | | $ | 5,471,183 | | |
Name and Address of Beneficial Owner of Shares of New Senior Common Stock(1)
|
| |
Amount and
Nature of Beneficial Ownership |
| |
Percent of
Class(2) |
| ||||||
Beneficial Owners of More than 5% of New Senior Common Stock | | | | | | | | | | | | | |
The Vanguard Group(3)
|
| | | | 8,021,620 | | | | | | 9.5% | | |
Fortress Investment Group LLC and certain affiliates(4)
|
| | | | 6,712,134 | | | | | | 8.0% | | |
BlackRock, Inc.(5)
|
| | | | 6,027,271 | | | | | | 7.2% | | |
Renaissance Technologies LLC(6)
|
| | | | 5,171,453 | | | | | | 6.2% | | |
Leon G. Cooperman(7)
|
| | | | 5,094,600 | | | | | | 6.1% | | |
Versor Investments LP / Asset Management Exchange Master ICAV(8)
|
| | | | 4,576,377 | | | | | | 5.4% | | |
Named Executive Officers and Directors: | | | | | | | | | | | | | |
Frances Aldrich Sevilla-Sacasa(9)
|
| | | | 9,404 | | | | | | * | | |
Susan Givens(9)
|
| | | | 1,772,380 | | | | | | 2.1% | | |
Norman K. Jenkins(9)
|
| | | | 11,874 | | | | | | * | | |
Michael D. Malone(9)
|
| | | | 73,537 | | | | | | * | | |
Lori B. Marino(9)
|
| | | | 269,559 | | | | | | * | | |
David H. Milner(9)
|
| | | | 198,618 | | | | | | * | | |
Bhairav Patel(9)
|
| | | | 309,352 | | | | | | * | | |
Robert F. Savage(9)
|
| | | | 348,708 | | | | | | * | | |
Cassia van der Hoof Holstein(9)
|
| | | | 75,670 | | | | | | * | | |
All executive officers and directors as a group (nine persons)
|
| | | | 3,069,102 | | | | | | 3.7% | | |
|
Ventas
|
| |
New Senior Investment Group
|
|
|
Authorized Stock
|
| |||
| Ventas is authorized to issue: | | | New Senior is authorized to issue: | |
| 600,000,000 shares of Ventas Common Stock, of which 380,352,586 shares were issued and outstanding as of August 6, 2021. | | | 2,000,000,000 shares of New Senior Common Stock, of which 84,063,182 shares were issued and outstanding as of August 6, 2021. | |
| 10,000,000 shares of Ventas Preferred Stock, of which no shares were issued and outstanding as of August 6, 2021. | | | 100,000,000 shares of New Senior Preferred Stock, of which 200,000 shares were issued and outstanding as of June 30, 2021 and no shares were issued and outstanding as of August 6, 2021. | |
|
Preferred Stock
|
| |||
| The Ventas Board is authorized, without stockholder action, to issue Ventas Preferred Stock in one or more series from time to time and to establish, among other things, the designation, powers, preferences and relative, participating, optional and other rights of each series, including: the dividend rights and preferences, if any; the liquidation preferences; redemption terms, if any; the voting powers of the series, if any; the terms upon which the series may be converted into Ventas Common Stock or other series of Ventas Preferred Stock. | | | The New Senior Board is similarly authorized to issue New Senior Preferred Stock in one or more classes without stockholder action. | |
|
Quorum
|
| |||
| At any meeting of stockholders, the holders of a majority of the issued and outstanding shares of stock entitled to vote present in person or represented by proxy constitute a quorum. If, however, such quorum is not present or represented at any meeting of the stockholders, the chairman of the meeting or a majority of the stockholders | | | At any meeting of stockholders, the holders of a majority of the capital stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, constitute a quorum. Where a separate vote by one or more series or classes is required, a majority in voting power of the outstanding shares of such one or more series or | |
|
Ventas
|
| |
New Senior Investment Group
|
|
| entitled to vote at the meeting, present in person or represented by proxy, is authorized to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is presented or represented. | | | classes present in person or by proxy constitute a quorum entitled to take action with respect to that vote on that matter. A quorum, once established, may not be broken by the withdrawal of enough votes to leave less than a quorum. If, however, such quorum is not present or represented at any meeting of the stockholders, the stockholders entitled to vote thereat, present in person or represented by proxy, have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present or represented. If the adjournment is for more than 30 days, notice of the adjourned meeting must be given. | |
|
Voting Rights
|
| |||
| Each record holder of Ventas Common Stock is entitled to one vote per share held by such record holder on all matters on which stockholders are generally entitled to vote. | | | Each record holder of New Senior Common Stock is entitled to vote at all meetings of the stockholders and has one vote for each share held by such record holder. | |
|
Special Meeting of Stockholders
|
| |||
| A special meeting of stockholders may be called at any time only by the Ventas Board or the chairman of the Ventas Board. Business transacted at the special meeting of stockholders will be limited to the purposes stated in the notice. Stockholders do not have the ability to call or cause a special meeting of stockholders. | | | A special meeting of stockholders may be called at any time by either (i) the chairman of the New Senior Board or (ii) the chief executive officer of New Senior, and may be called by any such officer at the request in writing of (i) the New Senior Board or (ii) a committee of the New Senior Board that has been duly designated by the New Senior Board and whose powers include the authority to call such meetings. Business transacted at the special meeting of stockholders will be limited to the purposes stated in the notice. Stockholders do not have the ability to call or cause a special meeting of stockholders. | |
|
Stockholder Action by Written Consent Without a Meeting
|
| |||
| Any action required or permitted to be taken by the stockholders at any annual or special meeting of the stockholders may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the action to be taken, is signed by the holders of at least 80% of all the issued and outstanding shares of stock of Ventas entitled to vote thereon. | | | Any action required or permitted to be taken by the New Senior stockholders at any meeting of the stockholders may be taken without a meeting if a consent in writing, setting forth the action to be taken, is signed by all the stockholders entitled to vote with respect to the subject matter thereof. | |
|
Notice of Stockholder Meetings
|
| |||
| Not less than 10 nor more than 60 days before the date of each meeting, Ventas must provide written notice of such meeting to each stockholder entitled to vote at such meeting. The notice must state the place, date and hour of the meeting and, in the case of a special meeting, the purpose or purposes for which the meeting is called. | | | Not less than 10 nor more than 60 days before the date of each meeting, New Senior must give notice to each stockholder entitled to notice of and to vote at such meeting. The notice must state the place, if any, date and hour of the meeting (or the means of remote communication, if any, by which stockholders and proxyholders may be deemed to be | |
|
Ventas
|
| |
New Senior Investment Group
|
|
| | | | present in person) and describe the purpose or purposes for which the meeting is called. | |
|
Advance Notice Requirement for Director Nominations and Stockholder Proposals
|
| |||
|
Nominations of persons for election to the Ventas Board and the proposal of business other than nominations to be considered by the stockholders may be made at an annual meeting of stockholders only (1) pursuant to Ventas’s notice of such meeting (or any supplement thereto), (2) by, or at the direction of, the Ventas Board, (3) by a stockholder who was a stockholder of record at the time of giving timely and proper notice, who is entitled to vote at the annual meeting or (4) by any Eligible Stockholder (as defined in the Ventas Bylaws) in accordance with the proxy access provisions set forth in the Ventas Bylaws. For nominations or other business to be properly brought before an annual meeting of stockholders by a stockholder pursuant to the foregoing clause (3), the stockholder must have given timely and proper notice thereof in writing to the secretary of Ventas and such business must be a proper subject for stockholder action.
For such proposals and nominations to be timely, a stockholder’s notice (including required information and documents) must generally be delivered to the secretary of Ventas at the principal executive offices of Ventas not later than the close of business on the 120th day nor earlier than the close of business on the 150th day prior to the first anniversary of the date of Ventas’s proxy statement released to stockholders in connection with the preceding year’s annual meeting of stockholders, subject to extension in limited circumstances.
Nominations of persons for election to the Ventas Board may be made at a special meeting of stockholders at which directors are to be elected pursuant to Ventas’s notice of meeting only (1) by or at the direction of the Ventas Board or (2) provided that the Ventas Board has determined that directors shall be elected at such special meeting, by any stockholder of record at the time of giving timely and proper notice. For such nominations to be timely, a stockholder’s notice (including required information and documents) must be delivered to the secretary of Ventas at the principal executive offices of Ventas not later than the close of business on the later of the 30th day before such special meeting or the 10th day following the day on which public announcement is first made of the date of the special meeting and of the nominees to be proposed by the Ventas Board to be elected at such special meeting.
|
| |
Only such business (other than nominations for election to the New Senior Board, which are addressed below) may be transacted at an annual meeting as is either (1) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the New Senior Board (or any duly authorized committee thereof), (2) otherwise properly brought before the annual meeting by or at the direction of the New Senior Board (or any duly authorized committee thereof), or (3) otherwise properly brought before the annual meeting by any stockholder (i) who is a stockholder of record on the date of the giving of the required notice and on the record date for the determination of stockholders entitled to notice of and to vote at such annual meeting and (ii) who gives timely and proper notice.
Nominations of persons for election to the New Senior Board may be made at any annual meeting, or at any special meeting of stockholders called for the purpose of electing directors, (1) by or at the direction of the New Senior Board (or any duly authorized committee thereof) or (2) by any stockholder of New Senior (i) who is a stockholder of record on the date of the giving of the required notice and on the record date for the determination of stockholders entitled to notice of and to vote at such annual meeting or special meeting and (ii) who gives timely and proper notice.
For such proposals and nominations to be timely, a stockholder’s notice (including required information and documents) to the secretary of New Senior must generally be delivered to or be mailed and received at the principal executive offices of New Senior (i) in the case of an annual meeting, not less than 90 days nor more than 120 days prior to the anniversary date of the immediately preceding annual meeting of stockholders, subject to extension in limited circumstances, and (ii) in the case of a special meeting called for the purpose of electing directors, not later than the close of business on the 10th day following the day on which the notice of the date of the special meeting was mailed or public disclosure of the date of the special meeting was made, whichever occurs first.
|
|
|
Ventas
|
| |
New Senior Investment Group
|
|
|
Proxy Access
|
| |||
| A stockholder or group of no more than 20 stockholders holding at least 3% of the outstanding Ventas Common Stock continuously for at least three years may nominate directors, so long as the number of directors elected via proxy access does not exceed 20% of the Ventas Board. Nominees who receive less than 25% of the votes would be ineligible for nomination under the proxy access provision for the next two annual meetings. For such nominations to be timely and proper, certain required information and documents must be submitted to the secretary of Ventas at the principal executive offices of Ventas not later than the close of business on the 120th day nor earlier than the close of business on the 150th day prior to the first anniversary of the date Ventas first distributed its definitive proxy statement for the preceding year’s annual meeting. | | |
A stockholder, or a group of up to 20 stockholders, holding at least 3% of the outstanding New Senior Common Stock for at least three years may nominate one director, so long as the number of directors elected via proxy access does not exceed 20% of the New Senior or two nominees, whichever is greater. Nominees who receive less than 25% of the votes would be ineligible for nomination under the proxy access provision for the next two annual meetings.
For such nominations to be timely and proper, certain required information and documents must be delivered to the secretary of New Senior at the principal executive offices of New Senior not later than the close of business on the 120th day nor earlier than the close of business on the 150th day prior to the first anniversary of the date New Senior first distributed its definitive proxy statement for the preceding year’s annual meeting.
|
|
|
Amendment of Charter
|
| |||
| The affirmative vote of the holders of not less than two-thirds of the votes entitled to be cast by the holders of shares entitled to vote generally in the election of directors is required to amend the provisions on “Restrictions of Ownership and Transfer; Designation of Excess Shares” contained in Article IX of the Ventas Charter. All other sections of the Ventas Charter may be amended by the affirmative vote of the holders of a majority of the outstanding shares entitled to vote in accordance with the DGCL. | | | The affirmative vote of at least 80% of the voting power of then issued and outstanding shares of capital stock of New Senior is required to amend, alter or repeal any provisions inconsistent with the intent and purpose of Articles FIFTH (matters related to the New Senior Board), EIGHTH (stockholder actions by written consent), TENTH (amendments to the New Senior Bylaws) or THIRTEENTH (amendments to the New Senior Charter) of the New Senior Charter. All other sections of the New Senior Charter may be amended by the affirmative vote of the holders of a majority of the outstanding shares entitled to vote in accordance with the DGCL. | |
|
Bylaws Amendments
|
| |||
| The Ventas Bylaws may be amended (i) by the affirmative vote of the holders of at least two-thirds of the voting power of all shares entitled to vote in the election of directors or (ii) by action of the Ventas Board at a regular or special meeting thereof. Any bylaws made by the Ventas Board may be amended or repealed by action of the stockholders at any annual or special meeting of stockholders. | | | The New Senior Bylaws may be amended (i) by the affirmative vote of at least two-thirds of the voting power of the then issued and outstanding shares of capital stock of New Senior entitled to vote thereon or (ii) by the affirmative vote of a majority of the entire New Senior Board. Notwithstanding the foregoing, any amendment of Section 2.3 (Special Meetings), Section 2.11 (Consent of Stockholders in Lieu of Meeting), Section 3.1 (Duties and Powers), Section 3.2 (Number and Election of Directors), Section 3.3 (Vacancies), Section 3.6 (Resignations and Removals of Directors), Article XI (Amendments) and Article XII (Definitions) of the New Senior Bylaws requires the affirmative vote of the holders of at least 80% of the voting power of | |
|
Ventas
|
| |
New Senior Investment Group
|
|
| | | | the then issued and outstanding shares of capital stock of New Senior entitled to vote thereon. | |
|
Number and Term of Directors
|
| |||
| As of the date of this proxy statement/prospectus, there are 11 directors on the Ventas Board. | | | As of the date of this proxy statement/prospectus, there are seven directors on the New Senior Board | |
|
The number of directors may be changed from time to time by a majority of the Ventas Board then in office, but in no event will be less than three nor more than 13.
Directors serve one-year terms and all directors are elected at each annual meeting.
|
| |
The number of directors may be changed from time to time by a majority of the entire New Senior Board, but in no event may the New Senior Board consist of less than three or more than nine members.
The New Senior Board is comprised of three director classes with each class consisting, as nearly as may be possible, of one-third of the total number of directors constituting the entire New Senior Board. Directors serve three-year terms and only one class of directors is elected at each annual meeting.
|
|
|
Election of Directors
|
| |||
|
Each director must be elected by the vote of the “majority of votes cast” (as defined below) with respect to that director’s election at any meeting for the election of directors at which a quorum is present, unless the election is contested, in which case directors shall be elected by the vote of a plurality of the shares of stock entitled to vote on the election of directors present in person or represented by proxy at any such meeting.
For the purpose of this section only, “majority of votes cast” means that the number of votes cast “for” a director’s election exceeds the number of votes cast “against” that director’s election (with “abstentions” and broker non-votes not counted as a vote cast either “for” or “against” that director’s election). If directors are to be elected by a plurality of the votes cast, stockholders are not permitted to vote “against” a candidate. |
| | Each director must be elected by a plurality of the votes of the shares of capital stock of New Senior, present in person or represented by proxy, and entitled to vote on the election of directors at any meeting of stockholders or in any action by written consent in lieu of such a meeting. If directors are to be elected by a plurality of the votes cast, stockholders are not permitted to vote “against” a nominee. | |
|
Removal of Directors
|
| |||
| The Ventas Bylaws provide that any director or the entire Ventas Board may be removed with or without cause, at any time, by the affirmative vote of the holders of record of a majority of the outstanding shares of stock entitled to vote in the election of directors, at a special meeting of the stockholders called for that purpose. | | | The New Senior Charter and New Senior Bylaws provide that any director may be removed only for cause and only by the affirmative vote of the holders of at least 80% of the voting power of the then issued and outstanding shares of capital stock entitled to vote in an election of directors. | |
|
Filling Vacancies on the Board
|
| |||
| The Ventas Bylaws provide that if any vacancy occurs on the Ventas Board for any reason, including, but not limited to, the resignation, removal or death of a director or an increase in the number of authorized directors, a majority of the | | | The New Senior Charter and New Senior Bylaws provide that (i) any vacancy on the New Senior Board that results from an increase in the number of directors may be filled by a majority of the directors then in office, provided that a quorum is present, | |
|
Ventas
|
| |
New Senior Investment Group
|
|
| Ventas Board in a specific case upon receipt of an undertaking by or on behalf of that person to repay such amounts, unless it is ultimately determined that such person is entitled to be indemnified as authorized by the DGCL. Expenses incurred by a person in any capacity other than as one of Ventas’s officers or directors may be paid in advance of the final disposition of a proceeding on such terms and conditions, if any, as the Ventas Board deems appropriate. | | | officer receiving the advancement to repay the amount advanced if it shall ultimately be determined that such person is not entitled to be indemnified by New Senior. | |
| Pursuant to Section 102(b)(7) of the DGCL, the Ventas Charter eliminates certain liability of its directors for breach of their fiduciary duty of care. | | | Pursuant to Section 102(b)(7) of the DGCL, the New Senior Charter eliminates certain liability of its directors for breach of their fiduciary duty of care. | |
| | |
Page
|
| |||
| | | | A-1 | | | |
| | | | A-1 | | | |
| | | | A-2 | | | |
| | | | A-2 | | | |
| | | | A-2 | | | |
| | | | A-2 | | | |
| | | | A-2 | | | |
| | | | A-2 | | | |
| | | | A-3 | | | |
| | | | A-6 | | | |
| | | | A-6 | | | |
| | | | A-7 | | | |
| | | | A-7 | | | |
| | | | A-7 | | | |
| | | | A-7 | | | |
| | | | A-22 | | | |
| | | | A-28 | | | |
| | | | A-28 | | | |
| | | | A-32 | | | |
| | | | A-34 | | | |
| | | | A-34 | | | |
| | | | A-35 | | | |
| | | | A-36 | | | |
| | | | A-37 | | | |
| | | | A-40 | | | |
| | | | A-40 | | | |
| | | | A-41 | | | |
| | | | A-41 | | | |
| | | | A-43 | | | |
| | | | A-43 | | | |
| | | | A-43 | | | |
| | | | A-45 | | | |
| | | | A-46 | | | |
| | | | A-47 | | | |
| | | | A-47 | | | |
| | | | A-47 | | | |
| | | | A-47 | | | |
| | | | A-47 | | | |
| | | | A-47 | | | |
| | | | A-48 | | |
| | |
Page
|
| |||
| | | | A-49 | | | |
| | | | A-49 | | | |
| | | | A-50 | | | |
| | | | A-50 | | | |
| | | | A-52 | | | |
| | | | A-52 | | | |
| | | | A-52 | | | |
| | | | A-52 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-61 | | |
|
Acceptable Confidentiality Agreement
|
| | | | 53 | | |
|
Agreement
|
| | | | 1 | | |
|
Bankruptcy and Equity Exceptions
|
| | | | 13 | | |
|
Base Amount
|
| | | | 59 | | |
|
Blue Sky Laws
|
| | | | 13 | | |
|
Certificate of Merger
|
| | | | 2 | | |
|
Chosen Courts
|
| | | | 75 | | |
|
Closing
|
| | | | 2 | | |
|
Closing Date
|
| | | | 3 | | |
|
Code
|
| | | | 1 | | |
|
Company
|
| | | | 1 | | |
|
Company Adverse Recommendation Change
|
| | | | 53 | | |
|
Company Base Amount
|
| | | | 71 | | |
|
Company Board
|
| | | | 13 | | |
|
Company Board Recommendation
|
| | | | 49 | | |
|
Company Book-Entry Shares
|
| | | | 3 | | |
|
Company Certificates
|
| | | | 3 | | |
|
Company Common Stock
|
| | | | 3 | | |
|
Company Disclosure Letter
|
| | | | 9 | | |
|
Company Employees
|
| | | | 23 | | |
|
Company Intellectual Property
|
| | | | 27 | | |
|
Company Preferred Stock
|
| | | | 11 | | |
|
Company Properties
|
| | | | 24 | | |
|
Company Property
|
| | | | 24 | | |
|
Company Qualified DC Plan
|
| | | | 57 | | |
|
Company Required Vote
|
| | | | 24 | | |
|
Company SEC Documents
|
| | | | 14 | | |
|
Company Stockholders Meeting
|
| | | | 49 | | |
|
Company Tax Representation Letter
|
| | | | 45 | | |
|
Company Termination Fee
|
| | | | 71 | | |
|
Company’s REIT Counsel
|
| | | | 45 | | |
|
Continuing Employees
|
| | | | 56 | | |
|
Converted Entity
|
| | | | 62 | | |
|
DGCL
|
| | | | 1 | | |
|
Disregarded Entity
|
| | | | 62 | | |
|
DLLCA
|
| | | | 1 | | |
|
Effective Time
|
| | | | 2 | | |
|
Eligible Shares
|
| | | | 3 | | |
|
EPCRA
|
| | | | 80 | | |
|
Exchange Act
|
| | | | 14 | | |
|
Exchange Agent
|
| | | | 4 | | |
|
Exchange Fund
|
| | | | 4 | | |
|
Exchange Ratio
|
| | | | 1 | | |
|
Excluded Shares
|
| | | | 3 | | |
|
Form S-4
|
| | | | 48 | | |
|
Forward Merger
|
| | | | 1 | | |
|
Forward Merger Surviving Company
|
| | | | 2 | | |
|
Health Care Law
|
| | | | 29 | | |
|
HMTA
|
| | | | 80 | | |
|
Indemnified Parties
|
| | | | 58 | | |
|
Letter of Transmittal
|
| | | | 5 | | |
|
License
|
| | | | 28 | | |
|
Material Company Leases
|
| | | | 25 | | |
|
Medicaid
|
| | | | 28 | | |
|
Medicare
|
| | | | 28 | | |
|
Merger
|
| | | | 2 | | |
|
Merger Consideration
|
| | | | 1 | | |
|
Merger Sub
|
| | | | 1 | | |
|
New Plans
|
| | | | 57 | | |
|
NYSE
|
| | | | 7 | | |
|
Organizational Documents
|
| | | | 10 | | |
|
Outside Date
|
| | | | 69 | | |
|
Parent
|
| | | | 1 | | |
|
Parent Capitalization Date
|
| | | | 32 | | |
|
Parent Closing Price
|
| | | | 7 | | |
|
Parent Disclosure Letter
|
| | | | 31 | | |
|
Parent Preferred Stock
|
| | | | 32 | | |
|
Parent SEC Documents
|
| | | | 34 | | |
|
Parent Stock Issuance
|
| | | | 38 | | |
|
Parent Stock Options
|
| | | | 32 | | |
|
Parent Tax Representation Letter
|
| | | | 47 | | |
|
Parent’s REIT Counsel
|
| | | | 45 | | |
|
Parties
|
| | | | 1 | | |
|
Party
|
| | | | 1 | | |
|
Payoff Letters
|
| | | | 64 | | |
|
Permits
|
| | | | 28 | | |
|
Preferred Redemption
|
| | | | 31 | | |
|
Proxy Statement/Prospectus
|
| | | | 48 | | |
|
QRS
|
| | | | 11 | | |
|
Qualifying Income
|
| | | | 72 | | |
|
RCRA
|
| | | | 80 | | |
|
REIT Dividend
|
| | | | 60 | | |
|
REIT Requirements
|
| | | | 71 | | |
|
Reverse Merger
|
| | | | 2 | | |
|
Reverse Merger Surviving Company
|
| | | | 2 | | |
|
Sarbanes-Oxley Act
|
| | | | 14 | | |
|
Securities Act
|
| | | | 14 | | |
|
Structure Election
|
| | | | 2 | | |
|
Subsidiary REIT
|
| | | | 62 | | |
|
Surviving Company Preferred Stock
|
| | | | 2 | | |
|
Takeover Laws
|
| | | | 53 | | |
|
Tax Guidance
|
| | | | 72 | | |
|
Third Party Payor Programs
|
| | | | 28 | | |
|
Transfer Taxes
|
| | | | 61 | | |
|
TRS
|
| | | | 11 | | |
|
TSCA
|
| | | | 80 | | |
|
Voting Debt
|
| | | | 12 | | |
| | | | VENTAS, INC. | | |||
| | | | By: | | |
/s/ John D. Cobb
Name: John D. Cobb
Title:
Executive Vice President and Chief Investment Officer
|
|
| | | | CADENCE MERGER SUB LLC | | |||
| | | | By: | | |
/s/ John D. Cobb
Name: John D. Cobb
Title:
Authorized Signatory
|
|
| | | | NEW SENIOR INVESTMENT GROUP INC. | | |||
| | | | By: | | |
/s/ Lori B. Marino
Name: Lori B. Marino
Title:
EVP, General Counsel & Secretary
|
|
1 Year New Senior Investment Chart |
1 Month New Senior Investment Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions